Galapagos NV (GLPG)
USD 23.52
(2.08%)
USD 23.52
(2.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 211.69 Million EUR | 197.11% |
| 2022 | -217.99 Million EUR | -73.81% |
| 2021 | -125.42 Million EUR | 59.67% |
| 2020 | -311 Million EUR | -307.55% |
| 2019 | 149.84 Million EUR | 612.13% |
| 2018 | -29.25 Million EUR | 74.71% |
| 2017 | -115.7 Million EUR | -314.22% |
| 2016 | 54.01 Million EUR | 145.61% |
| 2015 | -118.41 Million EUR | -456.54% |
| 2014 | 33.21 Million EUR | 511.08% |
| 2013 | -8.07 Million EUR | -41.22% |
| 2012 | -5.72 Million EUR | 82.71% |
| 2011 | -33.09 Million EUR | -857.37% |
| 2010 | 4.37 Million EUR | 45.18% |
| 2009 | 3.01 Million EUR | 120.64% |
| 2008 | -14.58 Million EUR | 33.55% |
| 2007 | -21.94 Million EUR | -93.63% |
| 2006 | -11.33 Million EUR | -73.29% |
| 2005 | -6.54 Million EUR | -82.25% |
| 2004 | -3.58 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 8.98 Million EUR | -90.04% |
| 2024 Q1 | 90.22 Million EUR | -42.74% |
| 2023 Q3 | 25.83 Million EUR | 406.37% |
| 2023 Q4 | 157.55 Million EUR | 509.98% |
| 2023 Q2 | 5.1 Million EUR | -78.02% |
| 2023 Q1 | 23.2 Million EUR | 111.2% |
| 2023 FY | 211.69 Million EUR | 197.11% |
| 2022 FY | -217.99 Million EUR | -73.81% |
| 2022 Q4 | -207.2 Million EUR | -1061.34% |
| 2022 Q1 | -13.31 Million EUR | -181.41% |
| 2022 Q2 | -19.02 Million EUR | -42.96% |
| 2022 Q3 | 21.55 Million EUR | 213.28% |
| 2021 Q2 | -64.32 Million EUR | -787.2% |
| 2021 Q1 | 9.36 Million EUR | 116.17% |
| 2021 Q3 | -64.61 Million EUR | -0.44% |
| 2021 Q4 | 16.35 Million EUR | 125.3% |
| 2021 FY | -125.42 Million EUR | 59.67% |
| 2020 FY | -311 Million EUR | -307.55% |
| 2020 Q4 | -57.88 Million EUR | 29.32% |
| 2020 Q3 | -81.9 Million EUR | 28.8% |
| 2020 Q2 | -115.04 Million EUR | -127.35% |
| 2020 Q1 | -50.6 Million EUR | 56.18% |
| 2019 Q2 | -47.24 Million EUR | 2.89% |
| 2019 FY | 149.84 Million EUR | 612.13% |
| 2019 Q3 | 361.23 Million EUR | 864.53% |
| 2019 Q4 | -115.48 Million EUR | -131.97% |
| 2019 Q1 | -48.65 Million EUR | -425.33% |
| 2018 FY | -29.25 Million EUR | 74.71% |
| 2018 Q4 | 14.95 Million EUR | 0.77% |
| 2018 Q3 | 14.84 Million EUR | 168.16% |
| 2018 Q2 | -21.77 Million EUR | 41.6% |
| 2018 Q1 | -37.28 Million EUR | -24.91% |
| 2017 Q1 | -13.6 Million EUR | -129.61% |
| 2017 Q2 | -35.64 Million EUR | -161.98% |
| 2017 Q4 | -29.84 Million EUR | 18.46% |
| 2017 Q3 | -36.6 Million EUR | -2.71% |
| 2017 FY | -115.7 Million EUR | -314.22% |
| 2016 Q1 | 35.95 Million EUR | 163.07% |
| 2016 FY | 54.01 Million EUR | 145.61% |
| 2016 Q3 | -24.16 Million EUR | -549.34% |
| 2016 Q2 | -3.72 Million EUR | -110.35% |
| 2016 Q4 | 45.94 Million EUR | 290.15% |
| 2015 Q1 | -14.22 Million EUR | -38.15% |
| 2015 Q3 | -27.22 Million EUR | -36.42% |
| 2015 Q4 | -57 Million EUR | -109.4% |
| 2015 FY | -118.41 Million EUR | -456.54% |
| 2015 Q2 | -19.95 Million EUR | -40.27% |
| 2014 Q2 | -7.31 Million EUR | 0.0% |
| 2014 Q4 | -10.29 Million EUR | 16.66% |
| 2014 Q3 | -12.35 Million EUR | -69.03% |
| 2014 Q1 | -7.31 Million EUR | -34.82% |
| 2014 FY | 33.21 Million EUR | 511.08% |
| 2013 Q1 | -2.98 Million EUR | -371.43% |
| 2013 Q4 | -5.42 Million EUR | 0.0% |
| 2013 Q3 | -5.42 Million EUR | -81.78% |
| 2013 Q2 | -2.98 Million EUR | 0.0% |
| 2013 FY | -8.07 Million EUR | -41.22% |
| 2012 FY | -5.72 Million EUR | 82.71% |
| 2012 Q4 | 1.09 Million EUR | -60.93% |
| 2012 Q3 | 2.81 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2011 FY | -33.09 Million EUR | -857.37% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2010 FY | 4.37 Million EUR | 45.18% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 FY | 3.01 Million EUR | 120.64% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 Q2 | - EUR | 0.0% |
| 2008 FY | -14.58 Million EUR | 33.55% |
| 2008 Q4 | - EUR | 0.0% |
| 2007 FY | -21.94 Million EUR | -93.63% |
| 2006 FY | -11.33 Million EUR | -73.29% |
| 2005 FY | -6.54 Million EUR | -82.25% |
| 2004 FY | -3.58 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | 507.698% |
| Jaguar Health, Inc. | -41.3 Million USD | 612.584% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 238.371% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | 488.992% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 148.087% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | -305.908% |
| ContextLogic Inc. | -317 Million USD | 166.781% |
| MiMedx Group, Inc. | 67.43 Million USD | -213.909% |
| MEI Pharma, Inc. | 17.77 Million USD | -1090.781% |
| AlloVir, Inc. | -190.41 Million USD | 211.175% |
| Novavax, Inc. | -545.06 Million USD | 138.839% |
| Aptorum Group Limited | -2.82 Million USD | 7594.636% |
| Ardelyx, Inc. | -66.06 Million USD | 420.428% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 203.128% |
| Psyence Biomedical Ltd. | -51.15 Million USD | 513.802% |
| Vaxcyte, Inc. | -402.26 Million USD | 152.626% |
| Precigen, Inc. | -95.9 Million USD | 320.738% |
| Pharming Group N.V. | -10.54 Million USD | 2106.987% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 205.013% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | 962.556% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | 943.717% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 199.754% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | 1241.464% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 969.775% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 969.775% |
| Bicycle Therapeutics plc | -180.66 Million USD | 217.177% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 182.107% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | 877.212% |
| Acelyrin, Inc. | -381.64 Million USD | 155.47% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | 666.944% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | 720.794% |
| Senti Biosciences, Inc. | -92.91 Million USD | 327.83% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | 302.196% |
| AbCellera Biologics Inc. | -146.39 Million USD | 244.604% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | 702.439% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 218.231% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | 3266.746% |
| Chimerix, Inc. | -82.09 Million USD | 357.868% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | 820.99% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 1143.305% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | 574.622% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 514.621% |
| Elevation Oncology, Inc. | -45.7 Million USD | 563.191% |
| Alkermes plc | 355.75 Million USD | 40.494% |
| Fortress Biotech, Inc. | -60.63 Million USD | 449.122% |
| Fortress Biotech, Inc. | -60.63 Million USD | 449.122% |
| Agenus Inc. | -245.76 Million USD | 186.139% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | 359.496% |
| Dyadic International, Inc. | -6.79 Million USD | 3215.271% |
| ImmuCell Corporation | -5.77 Million USD | 3766.004% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | 22717.201% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | 287.407% |
| Lantern Pharma Inc. | -15.96 Million USD | 1426.295% |
| Immix Biopharma, Inc. | -15.42 Million USD | 1472.335% |
| Incyte Corporation | 597.59 Million USD | 64.575% |
| IO Biotech, Inc. | -86.08 Million USD | 345.922% |
| Janux Therapeutics, Inc. | -58.29 Million USD | 463.16% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | 1212.504% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | 458.914% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 228.633% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 2590.26% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | 388.624% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 156.66% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 136.956% |
| NextCure, Inc. | -62.72 Million USD | 437.511% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | 2219.938% |
| Onconetix, Inc. | -37.4 Million USD | 665.888% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | 636.227% |
| Opthea Limited | -220.24 Million USD | 196.12% |
| PDS Biotechnology Corporation | -42.94 Million USD | 592.981% |
| PureTech Health plc | -65.69 Million USD | 422.232% |
| Pyxis Oncology, Inc. | -73.79 Million USD | 386.891% |
| Seer, Inc. | -86.27 Million USD | 345.369% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | 1687911.785% |
| Clearside Biomedical, Inc. | -32.48 Million USD | 751.676% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | 1719.486% |
| VYNE Therapeutics Inc. | -28.45 Million USD | 844.05% |
| Wave Life Sciences Ltd. | -57.51 Million USD | 468.085% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | 440.048% |
| C4 Therapeutics, Inc. | -132.49 Million USD | 259.78% |
| ChromaDex Corporation | -4.93 Million USD | 4387.1% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | 6000.139% |
| Caribou Biosciences, Inc. | -102.07 Million USD | 307.404% |
| CRISPR Therapeutics AG | -153.61 Million USD | 237.815% |
| Precision BioSciences, Inc. | -61.31 Million USD | 445.239% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 231.548% |
| Innoviva, Inc. | 179.72 Million USD | -17.791% |
| Summit Therapeutics Inc. | -614.92 Million USD | 134.426% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | 415.989% |
| Aadi Bioscience, Inc. | -65.76 Million USD | 421.899% |
| ESSA Pharma Inc. | -26.58 Million USD | 896.382% |
| GlycoMimetics, Inc. | -36.89 Million USD | 673.714% |
| GT Biopharma, Inc. | -7.59 Million USD | 2886.587% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 187.71% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | -196.453% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | 530.979% |
| Alzamend Neuro, Inc. | -9.94 Million USD | 2228.09% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 186.198% |
| Aptose Biosciences Inc. | -51.2 Million USD | 513.414% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | 315.363% |
| Soligenix, Inc. | -6.14 Million USD | 3547.424% |
| Century Therapeutics, Inc. | -136.67 Million USD | 254.893% |
| Kura Oncology, Inc. | -152.63 Million USD | 238.699% |
| TScan Therapeutics, Inc. | -89.21 Million USD | 337.281% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | 2108.892% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | -37337.353% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | 37305.097% |
| Autolus Therapeutics plc | -208.38 Million USD | 201.59% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | 394.441% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | 399.028% |
| Eterna Therapeutics Inc. | -21.66 Million USD | 1077.003% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 193.983% |
| GRI Bio, Inc. | -13.03 Million USD | 1723.817% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | 5220.16% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | 270.608% |
| IGM Biosciences, Inc. | -246.41 Million USD | 185.91% |
| INmune Bio, Inc. | -30 Million USD | 805.469% |
| Heron Therapeutics, Inc. | -110.55 Million USD | 291.479% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 601.726% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 1426.285% |
| Entero Therapeutics, Inc. | -15.79 Million USD | 1440.28% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | 454.69% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | 309.255% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 176.667% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 188.989% |
| Verastem, Inc. | -87.36 Million USD | 342.308% |
| Abeona Therapeutics Inc. | -54.18 Million USD | 490.671% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 231.215% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | 281.468% |
| Histogen Inc. | -10.62 Million USD | 2093.193% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | 1581.771% |
| Surrozen, Inc. | -43.04 Million USD | 591.838% |
| Organovo Holdings, Inc. | -14.67 Million USD | 1542.962% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 4261.506% |
| Ovid Therapeutics Inc. | -52.33 Million USD | 504.473% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | 937.973% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | 885.868% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | 2633.144% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 240.118% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | 532.688% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | 812.185% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | 2132.089% |
| Apollomics, Inc. | -172.6 Million USD | 222.651% |
| Amarin Corporation plc | -59.11 Million USD | 458.129% |
| Mesoblast Limited | -87.95 Million USD | 340.685% |
| Turnstone Biologics Corp. | -55.2 Million USD | 483.509% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 244.049% |
| Synaptogenix, Inc. | -6.03 Million USD | 3605.786% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | 1406.127% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | 371.337% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 4518.209% |
| Monopar Therapeutics Inc. | -8.4 Million USD | 2619.544% |
| Exelixis, Inc. | 207.76 Million USD | -1.893% |
| Better Therapeutics, Inc. | -39.76 Million USD | 632.437% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 247.065% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 140.046% |
| NLS Pharmaceutics AG | -12.17 Million USD | 1839.209% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | 2815.913% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | 788.468% |
| Gritstone bio, Inc. | -138.49 Million USD | 252.861% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 428.391% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 5392.491% |
| Avid Bioservices, Inc. | -140.75 Million USD | 250.403% |
| Insmed Incorporated | -749.56 Million USD | 128.243% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | 1493.705% |
| MediWound Ltd. | -6.71 Million USD | 3252.129% |
| OmniAb, Inc. | -50.61 Million USD | 518.216% |
| Alector, Inc. | -130.39 Million USD | 262.356% |
| Seres Therapeutics, Inc. | -113.72 Million USD | 286.15% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | 508.311% |
| Zai Lab Limited | -334.62 Million USD | 163.265% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 165.341% |
| Aura Biosciences, Inc. | -76.4 Million USD | 377.061% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 190.225% |
| Immunic, Inc. | -93.61 Million USD | 326.143% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | 255.782% |
| Veracyte, Inc. | -74.4 Million USD | 384.524% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | 2858.069% |
| FibroGen, Inc. | -284.23 Million USD | 174.48% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 907.018% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 3123.427% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | 1224.093% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 48.968% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | 1038.581% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | -329.658% |
| TG Therapeutics, Inc. | 12.67 Million USD | -1570.589% |
| Galecto, Inc. | -38.34 Million USD | 652.027% |
| Calithera Biosciences, Inc. | -18.86 Million USD | 1222.109% |
| Fortrea Holdings Inc. | -3.4 Million USD | 6326.382% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | 267.159% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | 1315.881% |
| XBiotech Inc. | -24.55 Million USD | 962.064% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 428.391% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | 437.743% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | 315.082% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | 1087.992% |
| Theravance Biopharma, Inc. | -55.19 Million USD | 483.558% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 134.897% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | 410.156% |
| Vaxxinity, Inc. | -56.93 Thousand USD | 371928.784% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 193.448% |
| Gain Therapeutics, Inc. | -22.26 Million USD | 1050.699% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 196.353% |
| NexImmune, Inc. | -32.34 Million USD | 754.509% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | 4104.427% |
| Marker Therapeutics, Inc. | -14.04 Million USD | 1607.181% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 94.645% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | 974.023% |
| Scopus BioPharma Inc. | -11.6 Million USD | 1923.429% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | 281.251% |
| Ainos, Inc. | -13.77 Million USD | 1637.317% |
| Pluri Inc. | -20.88 Million USD | 1113.486% |
| Prothena Corporation plc | -147.02 Million USD | 243.984% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | 285.909% |
| Celularity Inc. | -196.29 Million USD | 207.846% |
| Rallybio Corporation | -74.56 Million USD | 383.913% |
| Cue Biopharma, Inc. | -50.73 Million USD | 517.277% |
| MeiraGTx Holdings plc | -84.02 Million USD | 351.939% |
| Omeros Corporation | -117.81 Million USD | 279.689% |
| Humacyte, Inc. | -110.77 Million USD | 291.104% |
| Immunocore Holdings plc | -55.28 Million USD | 482.906% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | 1277.141% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | 1023.191% |
| Blueprint Medicines Corporation | -506.98 Million USD | 141.756% |
| CalciMedica, Inc. | -34.35 Million USD | 716.168% |
| Cabaletta Bio, Inc. | -67.67 Million USD | 412.814% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 249.71% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 227.691% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 174.737% |
| Pulmatrix, Inc. | -14.12 Million USD | 1599.164% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | 701.497% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | 356.174% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 143.994% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | 301.864% |
| Cytokinetics, Incorporated | -526.24 Million USD | 140.228% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | 686.987% |
| Nutriband Inc. | -5.48 Million USD | 3959.342% |
| Protara Therapeutics, Inc. | -40.42 Million USD | 623.743% |
| Vor Biopharma Inc. | -117.86 Million USD | 279.613% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 95.132% |
| Evogene Ltd. | -23.87 Million USD | 986.54% |
| ProKidney Corp. | -35.46 Million USD | 696.868% |
| Applied Therapeutics, Inc. | -119.76 Million USD | 276.763% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | 2798.362% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 132.913% |
| CorMedix Inc. | -46.33 Million USD | 556.842% |
| BioLineRx Ltd. | -60.61 Million USD | 449.254% |
| Tango Therapeutics, Inc. | -101.74 Million USD | 308.068% |
| Galectin Therapeutics Inc. | -41.06 Million USD | 615.504% |
| Atai Life Sciences N.V. | -40.22 Million USD | 626.295% |
| Renovaro Biosciences Inc. | -80.65 Million USD | 362.488% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | 380.315% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 172.452% |
| Sagimet Biosciences Inc. | -27.87 Million USD | 859.424% |
| MediciNova, Inc. | -8.57 Million USD | 2569.773% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | 271.725% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 2627.172% |
| GeoVax Labs, Inc. | -25.96 Million USD | 915.261% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 188.488% |
| Biomea Fusion, Inc. | -117.25 Million USD | 280.544% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 133.785% |
| Mereo BioPharma Group plc | -29.46 Million USD | 818.445% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 238.218% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 201.116% |
| Absci Corporation | -110.56 Million USD | 291.467% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 802.146% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | 309.94% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 189.726% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | -1403.103% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 209.709% |
| Allakos Inc. | -185.7 Million USD | 213.999% |
| Imunon, Inc. | -19.51 Million USD | 1184.792% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | 317.493% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | -99.451% |
| BioAtla, Inc. | -123.46 Million USD | 271.467% |
| NLS Pharmaceutics AG | -12.17 Million USD | 1839.209% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | 1416.687% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 164.687% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | 672.944% |
| XOMA Corporation | -40.83 Million USD | 618.471% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | 307.811% |
| Cara Therapeutics, Inc. | -118.51 Million USD | 278.628% |
| aTyr Pharma, Inc. | -50.38 Million USD | 520.125% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | 341.446% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 239.496% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 189.048% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | 702.799% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | 2716.146% |
| Akari Therapeutics, Plc | -10 Million USD | 2215.278% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 314540.401% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 24.822% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 3276.297% |
| UroGen Pharma Ltd. | -102.24 Million USD | 307.051% |
| Sutro Biopharma, Inc. | -106.79 Million USD | 298.231% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | 2822.026% |
| Orgenesis Inc. | -55.36 Million USD | 482.394% |
| Entera Bio Ltd. | -8.88 Million USD | 2481.561% |
| GH Research PLC | -35.58 Million USD | 694.872% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | 1115.821% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | 373.553% |
| Xencor, Inc. | -126.08 Million USD | 267.898% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | 5721.714% |
| Replimune Group, Inc. | -215.79 Million USD | 198.101% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | 1095.447% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | -8337.505% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 3276.297% |
| Portage Biotech Inc. | -75.33 Million USD | 380.993% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 2627.172% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | 319.023% |
| OncoCyte Corporation | -27.78 Million USD | 862.021% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | 1677.802% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | 2003.49% |
| Purple Biotech Ltd. | -19.88 Million USD | 1164.874% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | 3116.056% |
| scPharmaceuticals Inc. | -54.81 Million USD | 486.238% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | 1309.273% |
| HilleVax, Inc. | -123.56 Million USD | 271.323% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | 2194.558% |
| Tharimmune, Inc. | -9.31 Million USD | 2371.648% |
| Genprex, Inc. | -30.86 Million USD | 785.981% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 189.731% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | 803.453% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | 11979.742% |
| Virios Therapeutics, Inc. | -5.29 Million USD | 4097.289% |
| OKYO Pharma Limited | -16.82 Thousand USD | 1258294.427% |
| Savara Inc. | -54.69 Million USD | 487.029% |
| Curis, Inc. | -47.41 Million USD | 546.496% |
| Daré Bioscience, Inc. | -30.16 Million USD | 801.881% |
| Carmell Therapeutics Corporation | -15.44 Million USD | 1470.643% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | 3901.347% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | 810.035% |
| BeiGene, Ltd. | -881.7 Million USD | 124.01% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | 1094.163% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 148.514% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | 368.124% |
| Erasca, Inc. | -125.04 Million USD | 269.301% |
| bluebird bio, Inc. | -211.91 Million USD | 199.898% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 4333.519% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | -26.277% |
| DBV Technologies S.A. | -72.72 Million USD | 391.088% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 4333.519% |
| Moderna, Inc. | -4.71 Billion USD | 104.491% |
| Vincerx Pharma, Inc. | -40.15 Million USD | 627.173% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | 3817.896% |
| Molecular Templates, Inc. | -8.12 Million USD | 2705.822% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | 450.561% |
| Travere Therapeutics, Inc. | -111.39 Million USD | 290.035% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | 256.405% |
| Spruce Biosciences, Inc. | -47.91 Million USD | 541.781% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 249.684% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 210.024% |
| MacroGenics, Inc. | -9.05 Million USD | 2437.127% |
| RenovoRx, Inc. | -10.23 Million USD | 2168.97% |
| Adicet Bio, Inc. | -142.65 Million USD | 248.395% |
| Prime Medicine, Inc. | -198.13 Million USD | 206.846% |
| Aditxt, Inc. | -32.38 Million USD | 753.772% |
| Adagene Inc. | -18.94 Million USD | 1217.349% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 2995.309% |
| Quantum-Si incorporated | -95.96 Million USD | 320.61% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | 277.853% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 1552.191% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | -59.977% |
| SciSparc Ltd. | -5.12 Million USD | 4233.093% |
| Vericel Corporation | -3.18 Million USD | 6752.954% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 176141.545% |
| Minerva Neurosciences, Inc. | -30 Million USD | 805.531% |
| Generation Bio Co. | -126.61 Million USD | 267.201% |
| Astria Therapeutics, Inc. | -72.89 Million USD | 390.43% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | 356.783% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 180.757% |
| Invivyd, Inc. | -198.64 Million USD | 206.572% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 161.905% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | 2537.06% |
| Spero Therapeutics, Inc. | 22.8 Million USD | -828.251% |
| Artelo Biosciences, Inc. | -9.87 Million USD | 2243.984% |
| 2seventy bio, Inc. | -217.57 Million USD | 197.301% |
| ADMA Biologics, Inc. | -28.23 Million USD | 849.662% |
| Clene Inc. | -49.5 Million USD | 527.636% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | 1049.845% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | 528.242% |
| GeoVax Labs, Inc. | -25.96 Million USD | 915.261% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 164.529% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | 750.516% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | -831.765% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | 314.286% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 383.192% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 231.648% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 134.419% |
| Evaxion Biotech A/S | -22.12 Million USD | 1056.823% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | 362.209% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 205.813% |
| Trevena, Inc. | -40.28 Million USD | 625.446% |
| Surrozen, Inc. | -43.04 Million USD | 591.838% |
| Tyra Biosciences, Inc. | -69.13 Million USD | 406.213% |
| Cingulate Inc. | -23.53 Million USD | 999.501% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | 3162.746% |
| Unity Biotechnology, Inc. | -39.86 Million USD | 631.101% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | 2845.506% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | 334.671% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | 445.425% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | 455.775% |
| Clearmind Medicine Inc. | -11.95 Million USD | 1870.778% |
| Kronos Bio, Inc. | -112.67 Million USD | 287.886% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | 405.934% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 8347016.486% |
| Viking Therapeutics, Inc. | -85.89 Million USD | 346.46% |
| Statera Biopharma, Inc. | -174.4 Million USD | 221.38% |
| ImmunityBio, Inc. | -583.19 Million USD | 136.299% |
| Korro Bio, Inc. | -81.17 Million USD | 360.801% |
| Kineta, Inc. | -14.09 Million USD | 1601.504% |
| BioVie Inc. | -32.12 Million USD | 759.071% |
| Codexis, Inc. | -76.24 Million USD | 377.672% |
| Celularity Inc. | -196.29 Million USD | 207.846% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 198.68% |
| Celcuity Inc. | -63.77 Million USD | 431.922% |
| Virax Biolabs Group Limited | -6.73 Million USD | 3243.92% |
| Cibus, Inc. | -267.62 Million USD | 179.102% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | 624.964% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | 691.151% |
| IN8bio, Inc. | -30 Million USD | 805.492% |
| Kodiak Sciences Inc. | -260.49 Million USD | 181.268% |
| Annexon, Inc. | -134.23 Million USD | 257.704% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | 280.683% |
| Assembly Biosciences, Inc. | -61.22 Million USD | 445.752% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | 771.117% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 157.796% |
| Eyenovia, Inc. | -27.26 Million USD | 876.554% |
| Puma Biotechnology, Inc. | 21.59 Million USD | -880.487% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 39669.533% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | 377.076% |
| Arcellx, Inc. | -70.69 Million USD | 399.472% |
| Cardiff Oncology, Inc. | -41.44 Million USD | 610.84% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | 258.2% |
| Regulus Therapeutics Inc. | -30.03 Million USD | 804.787% |
| Moolec Science SA | -51.78 Million USD | 508.769% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | 504.226% |
| Geron Corporation | -184.12 Million USD | 214.973% |
| LAVA Therapeutics N.V. | -41.97 Million USD | 604.353% |
| Royalty Pharma plc | 1.13 Billion USD | 81.346% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | 255.71% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | 2480.811% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | 1096.539% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 223.316% |
| Humacyte, Inc. | -110.77 Million USD | 291.104% |
| Structure Therapeutics Inc. | -89.62 Million USD | 336.216% |
| 89bio, Inc. | -142.18 Million USD | 248.884% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | 406.985% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | 2140.06% |
| Genelux Corporation | -28.29 Million USD | 848.125% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | 828.357% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 219.522% |
| Notable Labs, Ltd. | -11.26 Million USD | 1979.412% |
| Liquidia Corporation | -78.5 Million USD | 369.671% |
| Mustang Bio, Inc. | -51.6 Million USD | 510.25% |
| Immunovant, Inc. | -259.33 Million USD | 181.63% |
| Quantum-Si incorporated | -95.96 Million USD | 320.61% |
| Arbutus Biopharma Corporation | -72.84 Million USD | 390.597% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | 1192.291% |
| Vera Therapeutics, Inc. | -95.99 Million USD | 320.541% |
| Acasti Pharma Inc. | -12.85 Million USD | 1747.063% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | 1042.641% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 1426.285% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 216.066% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | 5021.45% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | 1797.65% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | 817.836% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | 642.98% |
| PepGen Inc. | -78.62 Million USD | 369.246% |
| Moleculin Biotech, Inc. | -29.76 Million USD | 811.132% |
| United Therapeutics Corporation | 984.8 Million USD | 78.504% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | 1051.02% |
| Solid Biosciences Inc. | -96.01 Million USD | 320.483% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 4518.209% |
| Immuneering Corporation | -53.47 Million USD | 495.905% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 4261.506% |
| Silo Pharma, Inc. | -3.7 Million USD | 5820.485% |
| Belite Bio, Inc | -31.63 Million USD | 769.249% |
| XOMA Corporation | -40.83 Million USD | 618.471% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | 489.399% |
| Bionomics Limited | -15.49 Billion USD | 101.366% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 352.065% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 826.059% |
| uniQure N.V. | -308.47 Million USD | 168.626% |
| Cassava Sciences, Inc. | -97.21 Million USD | 317.757% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 2995.309% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | 271.512% |
| Forte Biosciences, Inc. | -31.47 Million USD | 772.566% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | 2681.135% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | 828.282% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 39669.533% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 907.018% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | 1384.18% |
| Altimmune, Inc. | -88.44 Million USD | 339.349% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 239.657% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 826.059% |
| Compugen Ltd. | -18.75 Million USD | 1228.81% |
| Peak Bio, Inc. | -1259.26 USD | 16811322.464% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | 559.721% |
| Benitec Biopharma Inc. | -21.75 Million USD | 1073.275% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 162.486% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | 355.198% |
| Zura Bio Limited | -60.36 Million USD | 450.724% |
| PolyPid Ltd. | -23.86 Million USD | 987.061% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | 1445.646% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | 355.198% |
| Instil Bio, Inc. | -156.08 Million USD | 235.628% |
| argenx SE | -295.05 Million USD | 171.749% |
| Immunome, Inc. | -106.8 Million USD | 298.207% |
| Compass Therapeutics, Inc. | -42.49 Million USD | 598.181% |
| Verona Pharma plc | -54.36 Million USD | 489.371% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | 311.873% |
| Shattuck Labs, Inc. | -87.29 Million USD | 342.499% |
| CervoMed Inc. | -2.17 Million USD | 9847.209% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | 269.832% |
| Plus Therapeutics, Inc. | -13.31 Million USD | 1689.794% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | 586.045% |
| Moolec Science SA | -51.78 Million USD | 508.769% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | 1224367.323% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | 256.676% |
| AnaptysBio, Inc. | -163.61 Million USD | 229.384% |
| Design Therapeutics, Inc. | -66.86 Million USD | 416.618% |
| Leap Therapeutics, Inc. | -81.41 Million USD | 360.025% |
| NeurAxis, Inc. | -14.62 Million USD | 1547.334% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | 658.833% |
| Lumos Pharma, Inc. | -34.03 Million USD | 722.016% |
| Achilles Therapeutics plc | -69.66 Million USD | 403.879% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | 311.873% |
| 180 Life Sciences Corp. | -19.93 Million USD | 1161.93% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | -6935.951% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 8347016.486% |
| Nutriband Inc. | -5.48 Million USD | 3959.342% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | 310.232% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | 535.528% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | 374.607% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | 723.188% |
| MoonLake Immunotherapeutics | -36 Million USD | 687.929% |
| Palisade Bio, Inc. | -12.3 Million USD | 1821.114% |
| Tourmaline Bio, Inc. | -42.12 Million USD | 602.557% |
| Beam Therapeutics Inc. | -132.52 Million USD | 259.739% |
| Neurogene Inc. | -36.31 Million USD | 682.914% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 229.546% |
| AEON Biopharma, Inc. | -52.55 Million USD | 502.803% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | 315.694% |
| Sesen Bio, Inc. | -19.88 Million USD | 1164.66% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | 395.732% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | 1791.695% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 147.676% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | 289.75% |
| Athira Pharma, Inc. | -117.67 Million USD | 279.904% |
| Vaccinex, Inc. | -20.25 Million USD | 1145.366% |
| HCW Biologics Inc. | -24.99 Million USD | 946.982% |
| XOMA Corporation | -40.83 Million USD | 618.471% |
| Nektar Therapeutics | -276.05 Million USD | 176.686% |
| Arvinas, Inc. | -367.3 Million USD | 157.636% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 314540.401% |
| Merus N.V. | -154.93 Million USD | 236.632% |
| Omega Therapeutics, Inc. | -97.42 Million USD | 317.286% |
| Quince Therapeutics, Inc. | -31.38 Million USD | 774.516% |
| Rezolute, Inc. | -68.45 Million USD | 409.232% |
| Clene Inc. | -49.5 Million USD | 527.636% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 1472.564% |
| BeyondSpring Inc. | -21.02 Million USD | 1106.834% |
| Synlogic, Inc. | -57.28 Million USD | 469.57% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | 1878.817% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 2055.45% |
| Peak Bio, Inc. | -1259.26 USD | 16811322.464% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | 666.519% |
| Krystal Biotech, Inc. | 10.93 Million USD | -1836.489% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 247.937% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 165.117% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | 4683.213% |
| MannKind Corporation | -11.93 Million USD | 1873.304% |
| Ikena Oncology, Inc. | -68.16 Million USD | 410.561% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | 1107.361% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | 327.795% |
| Gossamer Bio, Inc. | -179.81 Million USD | 217.729% |
| CohBar, Inc. | -11.96 Million USD | 1869.728% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | 920.913% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 802.146% |
| Legend Biotech Corporation | -518.25 Million USD | 140.848% |
| Mural Oncology plc | -207.44 Million USD | 202.049% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 270.565% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | 1257.464% |
| Disc Medicine, Inc. | -76.42 Million USD | 376.985% |
| Champions Oncology, Inc. | -7.27 Million USD | 3009.524% |
| REGENXBIO Inc. | -263.49 Million USD | 180.342% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | 2094.681% |
| Anavex Life Sciences Corp. | -47.5 Million USD | 545.631% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | 657.339% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | 311.352% |
| Vaxart, Inc. | -82.46 Million USD | 356.711% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | -63327.342% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | 663.886% |
| Cellectis S.A. | -101.05 Million USD | 309.479% |
| Longeveron Inc. | -21.41 Million USD | 1088.638% |
| Repare Therapeutics Inc. | -93.79 Million USD | 325.699% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 139.497% |
| Inozyme Pharma, Inc. | -71.16 Million USD | 397.457% |
| Revolution Medicines, Inc. | -436.36 Million USD | 148.514% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | 3321.686% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | 786.793% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | 405.334% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | 427.036% |
| Anixa Biosciences, Inc. | -9.81 Million USD | 2257.752% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 94.151% |
| Denali Therapeutics Inc. | -145.22 Million USD | 245.773% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 176141.545% |
| Veru Inc. | -93.15 Million USD | 327.258% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | 883.222% |
| Cingulate Inc. | -23.53 Million USD | 999.501% |
| Passage Bio, Inc. | -102.06 Million USD | 307.42% |
| Context Therapeutics Inc. | -23.96 Million USD | 983.388% |
| Exicure, Inc. | -16.91 Million USD | 1351.608% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 212.058% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | 660.579% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | 3353.211% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 214.63% |
| Nuvalent, Inc. | -126.21 Million USD | 267.722% |
| ABVC BioPharma, Inc. | -10.51 Million USD | 2113.16% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | 343.669% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | 793.089% |
| OmniAb, Inc. | -50.61 Million USD | 518.216% |
| Anew Medical, Inc. | 1.34 Million USD | -15626.4% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | 1419.395% |
| Lipocine Inc. | -16.35 Million USD | 1394.618% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | 418.85% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | 432.465% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 601.726% |
| G1 Therapeutics, Inc. | -47.96 Million USD | 541.339% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | 1167.505% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 139.095% |
| Ocugen, Inc. | -63.07 Million USD | 435.611% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | 321.135% |
| Q32 Bio Inc. | -112.96 Million USD | 287.407% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | 1331.369% |
| Alumis Inc. Common Stock | -154.99 Million USD | 236.585% |
| Equillium, Inc. | -13.33 Million USD | 1687.529% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | 450.689% |
| Coya Therapeutics, Inc. | -7.98 Million USD | 2750.242% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | 1222.988% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 458.31% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 284.845% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | 1251.907% |
| Dominari Holdings Inc. | -22.88 Million USD | 1025.168% |
| Edesa Biotech, Inc. | -8.37 Million USD | 2627.902% |
| vTv Therapeutics Inc. | -20.25 Million USD | 1145.417% |
| Bio-Techne Corporation | 168.1 Million USD | -25.931% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 160.126% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | -64.293% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | 273.761% |
| Candel Therapeutics, Inc. | -37.93 Million USD | 657.993% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | 287.938% |
| Nkarta, Inc. | -117.5 Million USD | 280.166% |
| BioCardia, Inc. | -11.57 Million USD | 1929.548% |
| Iterum Therapeutics plc | -38.37 Million USD | 651.711% |